Results 91 to 100 of about 10,308 (248)
Alzheimer's &Dementia, Volume 20, Issue 9, Page 6456-6467, September 2024.Abstract INTRODUCTION Plasma phosphorylated tau (p‐tau)217 is a promising biomarker for Alzheimer's disease (AD) diagnosis, but its clinical implementation remains challenging. We propose a strategy based on Bayes’ theorem and test it in real‐life memory clinics.
Poosanu Thanapornsangsuth +9 more
wiley +1 more source
The Relationship Between KRAS Mutation and 18F-FDG Uptake Parameters in Colorectal Cancer
Bagcilar Medical Bulletin, 2022 Objective:Our purpose in this study was to evaluate whether Kirsten rat sarcoma viral oncogene (KRAS) exon-2 mutation affected 18F-fluorodeoxyglucose (FDG) accumulation patterns, total lesion glycolysis and metabolic tumor volume in colorectal cancer ...
Aynur Özen +7 more
doaj +1 more source
Autopet Challenge 2023: nnUNet-based whole-body 3D PET-CT Tumour Segmentation [PDF]
arXiv, 2023 Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) combined with Computed Tomography (CT) scans are critical in oncology to the identification of solid tumours and the monitoring of their progression. However, precise and consistent lesion segmentation remains challenging, as manual segmentation is time-consuming and subject to intra- and inter ...
arxiv
FEBS Open Bio, Volume 14, Issue 7, Page 1116-1132, July 2024.A low dose of streptozotocin (STZ) intracerebroventricularly (ICV) into the brain was used to reproduce Alzheimer's disease (AD) pathogenesis. Amino acid profiling of cerebrospinal fluid (CSF) was investigated to uncover potential disease biomarkers. Our results showed a reduction in the concentrations of various amino acids upon ICV‐STZ administration
Amir Barzegar Behrooz +6 more
wiley +1 more source
Imaging Hepatocellular Carcinoma With 68Ga-Citrate PET: First Clinical Experience. [PDF]
, 2017 While cross-sectional imaging with computed tomography (CT) and magnetic resonance imaging is the primary method for diagnosing hepatocellular carcinoma (HCC), they provide little biological insight into this molecularly heterogeneous disease.
Aggarwal, Rahul +7 more
core +2 more sources
Differential Synaptic Loss in β‐Amyloid Positive Versus β‐Amyloid Negative Corticobasal Syndrome
Movement Disorders, Volume 39, Issue 7, Page 1166-1178, July 2024.Abstract Background/Objective The corticobasal syndrome (CBS) is a complex asymmetric movement disorder, with cognitive impairment. Although commonly associated with the primary 4‐repeat‐tauopathy of corticobasal degeneration, clinicopathological correlation is poor, and a significant proportion is due to Alzheimer's disease (AD).
Negin Holland +15 more
wiley +1 more source
Veterinary Radiology &Ultrasound, Volume 65, Issue 4, Page 408-416, July 2024.Abstract Serial fluorine 18 fluorodeoxyglucose (18F‐FDG) positron emission tomography–CT (PET/CT) is commonly used in human oncology to prognosticate and evaluate for therapeutic effectiveness. In this pilot study, dogs with naturally occurring appendicular osteosarcoma were evaluated with serial 18F‐FDG PET/CT in an attempt to assess for response to ...
Tiffany W. Martin, Lynn Griffin
wiley +1 more source
DiagnosticsObjectives: The purpose of this study was to investigate the imaging characteristics of medication-related osteonecrosis of the jaw (MRONJ) using [18F]fluoride positron emission tomography/computed tomography (PET/CT) and [18F]fluorodeoxyglucose (FDG ...
Christian Philipp Reinert +8 more
doaj +1 more source
18F-FDG PET/MR Assessment of Pediatric Langerhans Cell Histiocytosis
International Journal of General Medicine, 2021 Jialing Niu,1,2 Jiangtao Liang,3 Qi Feng,2 Mei Wang,2 Luoyu Wang,4 Xiuhong Ge,2 Xiao Wang,5 Zhongxiang Ding2,6 1Zhejiang Chinese Medical University, Hangzhou, People’s Republic of China; 2Department of Radiology, Affiliated Hangzhou First People’s ...
Niu J +7 more
doaj
The Reconfiguration Pattern of Individual Brain Metabolic Connectome for Parkinson's Disease Identification [PDF]
arXiv, 2021 Background: Positron Emission Tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) reveals metabolic abnormalities in Parkinson's disease (PD) at a systemic level. Previous metabolic connectome studies derived from groups of patients have failed to identify the individual neurophysiological details.
arxiv